Neuropsychotoxicity of abused drugs: Effects of serotonin receptor ligands on methamphetamine-and cocaine-induced behavioral sensitization in mice

Journal of Pharmacological Sciences

Volumn 106, Issue 1, 2008, Pages 15-21

  Ago, Yukio ^a   Nakamura, Shigeo ^a   Baba, Akemichi ^a   Matsuda, Toshio ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Behavioral sensitization; Cocaine; Drugs of abuse; Methamphetamine; Serotonin (5 HT) receptor ligand

Indexed keywords

AZASETRON; COCAINE; LIGAND; METHAMPHETAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OSEMOZOTAN; RITANSERIN; SEROTONIN 1A AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN RECEPTOR;

BEHAVIOR; DRUG ABUSE; LOW DRUG DOSE; MICRODIALYSIS; NEUROCHEMISTRY; NEUROPSYCHOTOXICITY; NONHUMAN; PREFRONTAL CORTEX; PSYCHOSIS; SENSITIZATION; SHORT SURVEY; TOXICITY;

EID: 38549098081     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FM0070121     Document Type: Short Survey

References (47)

1. Pierce RC, Kalivas PW. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev. 1997;25:192-216.
2. White FJ, Kalivas PW. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 1998;51:141-153.
3. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nature Rev Neurosci. 2001;2:119-128.
4. Vanderschuren LJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology. 2000;151:99-120.
5. Wise RA. Brain reward circuitry: insights from unsensed incentives. Neuron. 2002;36:229-240.
6. Rothman RB, Grieg N, Kim A, De CB, Rice KC, Carroll FI, et al. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter. Pharmacol Biochem Behav. 1992;43:1135-1142.
7. Newman AH, Allen AC, Izenwasser S, Katz JL. Novel 3α- (diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J Med Chem. 1994;37:2258-2261.
8. Szumlinski KK, McCafferty CA, Maisonneuve IM, Glick SD. Interactions between 18-methoxycoronasidine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization. Brain Res. 2000;871:245-258.
9. Kuczenski R, Segal DS, Todd PK. Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology. 1997;134:221-229.
10. Segal DS, Kuczenski R. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 1992;571:330-337.
11. Iyo M, Bi Y, Hashimoto K, Inada T, Fukui S. Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram. Eur J Pharmacol. 1996;312:163-170.
12. Hamamura T, Fibiger HC. Enhanced stress-induced dopamine release in the prefrontal cortex of amphetamine-sensitized rats. Eur J Pharmacol. 1993;237:65-71.
13. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083-1152.
14. 1A receptors. Jpn J Pharmacol. 1995;69:357-366.
15. 2A serotonin receptor. J Pharmacol Sci. 2006;102:55-63.
16. Miyata K, Kamato T, Yamano M, Nishida A, Ito H, Katsuyama Y, et al. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats. J Pharmacol Exp Ther. 1991;259:815-819.
17. 1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology. 2006;51:914-922.
18. Ago Y, Nakamura S, Hayashi A, Itoh S, Baba A, Matsuda T. Effects of osemozotan, ritanserin and azasetron on cocaine-induced behavioral sensitization in mice. Pharmacol Biochem Behav. 2006;85:198-205.
19. Ago Y, Nakamura S, Kajita N, Uda M, Hashimoto H, Baba A, et al. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice. Synapse. 2007;61:757-763.
20. 1A receptors inhibits amphetamine sensitization in mice. Life Sci. 2000;66:1011-1019.
21. 1B receptors in the sensitization to amphetamine in mice. Eur J Pharmacol. 2001;422:91-99.
22. Tanaka T, Ishigooka J, Watanabe S, Nagata E, Miura S. Partial inhibition of reverse tolerance by a high dose of ritanserin or low dose of haloperidol in methamphetamine-sensitized rat. Jpn J Psychopharmcol. 1998;18:1-7.
23. 2A and α1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioral sensitization to opiates and psychostimulants. Eur J Neurosci. 2004;20:3073-3084.
24. 3A receptor channel and binding study. J Neurochem. 2006;99:976-988.
25. 1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology. 2003;45:1050-1056.
26. 1a-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse. 2002;45:67-77.
27. 1A-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Behav Brain Res. 2002;134:337-346.
28. 1B receptor ligands on cocaine sensitization in rats. Behav Pharmacol. 2001;12:109-116.
29. 2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization. Eur J Pharmacol. 2002;453:255-263.
30. 2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther. 2004;310:1246-1254.
31. 3 receptor antagonist, and cocaine. Psychopharmacology. 1997;130:159-165.
32. 3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine. Psychopharmacology. 1998;135:263-269.
33. 3 receptor antagonist. Eur J Pharmacol. 2000;394:97-101.
34. 1A agonist 8-hydroxy-2(di-n-propylamino) tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a microanalysis of locomotor activity. J Pharmacol Exp Ther. 2000;292:610-617.
35. 1A receptor stimulation upon cocaine-induced locomotion and sensitization. Neuropsychopharmacology. 2004;29:1675-1687.
36. 1A syndrome. Pharmacol Biochem Behav. 1997;57:897-908.
37. Dulawa SC, Geyer MA. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology. 2000;39:2170-2179.
38. Rigdon GC, Weatherspoon JK. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther. 1992;263:486-493.
39. Sipes TA, Geyer MA. 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology. 1995;117:41-48.
40. Narita M, Akai H, Nagumo Y, Sunagawa N, Hasebe K, Nagase H, et al. Implication of protein kinase C in the nucleus accumbens in the development of sensitization to methamphetamine in rats. Neuroscience. 2004;127:941-948.
41. 2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 1991;546:40-46.
42. 1 receptor agonist. Neuropharmacology. 2006;50:991-997.
43. Stephans SE, Yamamoto BY. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res. 1995;700:99-106.
44. Paulson PE, Robinson TE. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse. 1995;19:56-65.
45. Salomon L, Lanteri C, Glowinski J, Tassin JP. Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc Natl Acad Sci U S A. 2006;103:7476-7481.
46. 2A receptors: Effect of antipsychotic drugs. Eur J Neurosci. 2003;18:1235-1246.
47. Martín-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, et al. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci. 2001;21:9856-9866.